STEM vs DNA

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 04, 2026

STEM

43.9
AI Score
VS
DNA Wins

DNA

57.8
AI Score

Investment Advisor Scores

STEM

44score
Recommendation
HOLD

DNA

58score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric STEM DNA Winner
Revenue 29.00M 19.47M STEM
Net Income -18.93M -82.59M STEM
Net Margin -65.3% -424.1% STEM
Operating Income -14.21M -71.37M STEM
ROE 7.1% -18.6% STEM
ROA -6.7% -8.0% STEM
Total Assets 281.88M 1.03B DNA
Cash 36.59M 143.86M DNA
Current Ratio 0.84 5.15 DNA

Relative Price Performance (Last 90 Days)

STEM 1M: -28.4% · 3M: -47.8% DNA 1M: -14.0% · 3M: -7.8%

Current Technical Phase

STEM

Markdown
Sell / avoid

Price below a falling SMA50 (slope -16.7%), weak momentum, RSI 37

RSI (14): 37.1 · Price: $5.62

DNA

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 56

RSI (14): 56.4 · Price: $8.94

Fundamentals Snapshot

Metric STEM DNA
Market Cap
Forward P/E -1.0 -2.8
Trailing P/E
Revenue (TTM)
Revenue Growth -0.1% -0.5%
Gross Margin 0.4% 0.7%
Operating Margin -0.4% -3.7%
EPS -8.35 -5.38
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, DNA is currently the stronger investment candidate, winning 3 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.